Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,519
Ph III recruiting: 166
Growth YoY: +7.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,321)

clinicaltrialsPublishedShowing 501–550 of 1,522 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05019794	Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations(FGFR)	unknown	Phase 2	80	LianBio LLCINDUSTRY	1	Jun 27, 2022	clinicaltrials
NCT05429294	Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038	unknown	Phase 2	209	First Affiliated Hospital Xi'an Jiaotong UniversityOTHER	1	Jun 23, 2022